Show simple item record

dc.contributor.authorÇetiner, Esra
dc.contributor.authorSayın, Koray
dc.contributor.authorTüzün, Burak
dc.contributor.authorAtaseven, Hilmi
dc.date.accessioned2022-05-13T06:53:34Z
dc.date.available2022-05-13T06:53:34Z
dc.date.issued2021tr
dc.identifier.urihttps://hdl.handle.net/20.500.12418/12955
dc.description.abstractBACKGROUND: Seven dioxaborole compounds are investigated in this study. Structural and spectral characterizations are done at the M062X/6-31+G(d,p) level in water. Active sites of these compounds are determined by contour plots of frontier molecular orbital and molecular electrostatic potential (MEP) maps. Electrophilic and nucleophilic attack regions are determined. Since SARS-CoV-2 is a worldwide health problem, antiviral properties of studied boron-containing compounds are investigated by molecular docking calculations. In addition to these calculations, MM/PSBA calculations are performed. RESULTS AND CONCLUSION: It is found that the studied boron compounds can be good drug candidates against the main protease of SARS-CoV-2, while the best of them is 4,6-di-tert-butyl-2-(4-methoxyphenyl) benzo[d][1,3,2] dioxaborole (B2) (Tab. 3, Fig. 8, Ref. 23).tr
dc.language.isoengtr
dc.rightsinfo:eu-repo/semantics/restrictedAccesstr
dc.titleCould boron-containing compounds (BCCs) be effective against SARS-CoV-2 as anti-viral agent?tr
dc.typearticletr
dc.contributor.departmentTıp Fakültesitr
dc.relation.publicationcategoryRaportr


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record